4TH FLOOR, ST. PAUL'S GATE, ST. HELIER, Y9
Amended material disclosure
Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Ex-99.1
Earnings Release
Announces Sale of Life Sciences & Healthcare Segment for $600 Million, Investor Presentation
Q2
Q1
FY 2024
Q3
S-3ASR
Registration Statement for Securities to be Offered to Employees
Amended Registration of Securities
Certificate
Registration of Securities
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence